A case of complex movement disorder induced by fluoxetine with management of dystonia by botulinum toxin type A.
Chen
Jack J
JJ
Swope
David M
DM
D000368:Aged; D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy / Q000209:etiology; D020821:Dystonic Disorders / Q000139:chemically induced* / Q000188:drug therapy*; D005473:Fluoxetine / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009069:Movement Disorders / Q000188:drug therapy* / Q000209:etiology*; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use
D018726:Anti-Dyskinesia Agents; D019274:Botulinum Toxins, Type A; D005473:Fluoxetine; D009465:Neuromuscular Agents; D017367:Selective Serotonin Reuptake Inhibitors